Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

RBC Capital lowered the firm’s price target on Regeneron (REGN) to $1,045 from $1,059 but keeps an Outperform rating on the shares. The ...

Emerson Electric (NYSE: EMR), the St. Louis-based industrial technology and software company, unveiled its new corporate ...

The three-building Muse campus is a few miles from Breakthrough’s Torrey Heights campus, which opened in September.

The former IBM building next to Cleveland Clinic along Cleveland’s Opportunity Corridor will become Canon Healthcare USA Inc.'s national headquarters after Cleveland City Council approved the move at ...

Citadel’s Ken Griffin is forging ahead with his new Park Avenue office tower, filing plans with the city as the developers ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...